The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop the GlycoSense™ technology for monitoring glycosylation during glycoprotein production.
Lectenz Bio receives NIH NIGMS SBIR Phase II
Category: Lectenz Bio News
Date: September 15, 2023
Author: dschulz